Open Access

[Retracted] Isoquercitrin inhibits bladder cancer progression in vitro and in vivo by regulating the PI3K/Akt and PKC signaling pathways

  • Authors:
    • Feng Chen
    • Xiaochi Chen
    • Deyong Yang
    • Xiangyu Che
    • Jianbo Wang
    • Xiancheng Li
    • Zhiwei Zhang
    • Qifei Wang
    • Wei Zheng
    • Lina Wang
    • Xuejian Wang
    • Xishuang Song
  • View Affiliations

  • Published online on: December 18, 2023     https://doi.org/10.3892/or.2023.8684
  • Article Number: 25
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 36: [Related article:] 165–172, 2016; DOI: 10.3892/or.2016.4794

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the agarose gel electrophoretic bands shown in Fig. 4A for PKC were strikingly similar to bands that had already appeared in another article written by different authors at different research institutes.

Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

February-2024
Volume 51 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen F, Chen X, Yang D, Che X, Wang J, Li X, Zhang Z, Wang Q, Zheng W, Wang L, Wang L, et al: [Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways. Oncol Rep 51: 25, 2024.
APA
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X. ... Song, X. (2024). [Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways. Oncology Reports, 51, 25. https://doi.org/10.3892/or.2023.8684
MLA
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X., Zhang, Z., Wang, Q., Zheng, W., Wang, L., Wang, X., Song, X."[Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways". Oncology Reports 51.2 (2024): 25.
Chicago
Chen, F., Chen, X., Yang, D., Che, X., Wang, J., Li, X., Zhang, Z., Wang, Q., Zheng, W., Wang, L., Wang, X., Song, X."[Retracted] Isoquercitrin inhibits bladder cancer progression <em>in vitro</em> and <em>in vivo</em> by regulating the PI3K/Akt and PKC signaling pathways". Oncology Reports 51, no. 2 (2024): 25. https://doi.org/10.3892/or.2023.8684